Simulation Significantly Impacts Respiratory Systems Device Design by Reducing Clinical Tests

Share Article

CD-adapco webinar will demonstrate how the simulation of respiratory systems is a rapidly growing field within the life sciences industry, a market approaching $2 trillion in revenues

Simulation Significantly Impacts Respiratory Systems Device Design By Reducing Clinical Trial Tests

Simulations provide a means of gaining valuable insight into delicate, often inaccessible areas, allowing the use of patient-specific data.

This webinar will demonstrate how using engineering simulation tools, such as CD-adapco’s multidisciplinary CFD tool STAR-CCM+®, can help to reduce the dependency on expensive clinical testing when designing new devices.

CD-adapco, the largest privately held CFD-focused provider of Computer Aided Engineering software, is hosting a Life Sciences industry webinar on September 15, 2015, titled, “How Simulation is Impacting Respiratory Systems within Life Sciences.” This webinar will demonstrate how using engineering simulation tools, such as CD-adapco’s multidisciplinary CFD tool STAR-CCM+®, can help to reduce the dependency on expensive clinical testing when designing new devices.

Simulations provide a means of gaining valuable insight into delicate, often inaccessible areas, allowing the use of patient-specific data. With applications ranging from inhaler design optimization to the modeling of particle deposition into lungs and assessing the efficacy of inhaled medications, the simulation of respiratory systems is a significant growth area within the life sciences industry.

During this exclusive CD-adapco online event, Dr. Shahab Taherian of InFluids will discuss the importance and the future of diagnostics applications in the respiratory field. Other topics will also be explored, including device modeling, in silico modeling of nasal passages and respiratory tracts, diagnostics and virtual surgeries to aid the decision-making processes.

In addition, a live demonstration during this CD-adapco webinar will explore the detailed simulation of a lung model, and examine how you can utilize patient-specific data in your CDF simulations.

Registration for this CD-adapco webinar is available at http://bit.ly/1hj46AA.

About CD-adapco
CD-adapco (http://www.cd-adapco.com) is the world's largest independent CFD-focused CAE provider. Our core products are the technology-leading simulation packages, STAR-CCM+ and STAR-CD. The scope of our activities, however, extends well beyond CFD software development to encompass a wide range of CAE engineering services in fluid dynamics, heat transfer and structural engineering. Our ongoing mission is to "inspire innovation and reduce costs through the application of engineering simulation software and services."

A privately owned company, CD-adapco has maintained 15% organic year-on-year growth over the last 5 years. CD-adapco employs 900 talented individuals, working at 40 different offices across the globe.

###

Press Contact
Todd Mavreles, CD-adapco
todd.mavreles(at)cd-adapco(dot)com
(+1) 713 334 4311

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Todd Mavreles
CD-adapco
+1 (713) 301-8671
Email >
Visit website